RIG
43
-7
STT
64
2
ALL
50
2
GRMN
67
-4
FTI
71
-7
KMI
69
-2
NI
72
4
NWS
75
-4
C
62
4
EMR
71
-3
RL
69
-4
FSLR
44
-2
GOOG
57
-6
NAVI
52
-2
FOX
51
-6
CVX
43
-3
BMY
55
-8
MSI
72
-3
HSIC
45
5
TEL
60
-8
RIG
43
-7
STT
64
2
ALL
50
2
GRMN
67
-4
FTI
71
-7
KMI
69
-2
NI
72
4
NWS
75
-4
C
62
4
EMR
71
-3
RL
69
-4
FSLR
44
-2
GOOG
57
-6
NAVI
52
-2
FOX
51
-6
CVX
43
-3
BMY
55
-8
MSI
72
-3
HSIC
45
5
TEL
60
-8
Financhill
Back

Accuray Vs. Perspective Therapeutics Industry Stock Comparison

Sell
46

ARAY
Accuray

Last Price:
1.71
Seasonality Move:
17.35%
Sell
30

CATX
Perspective Therapeutics

Last Price:
7.88
Seasonality Move:
40.67%
Sell
46
Accuray (ARAY) is a Sell

Is Accuray a Buy, Sell or Hold?

  • The current Accuray [ARAY] share price is $1.70. The Score for ARAY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ARAY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $7.88. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARAY Stock Price Chart

What is Accuray's stock price today?

  • The Accuray share price today is $1.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARAY is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $7.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

ARAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 40.89 Sell
Chaikin Money Flow: -639616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.74 - 1.96) Sell
Bollinger Bands (100): (1.67 - 2.09) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 19.21 Sell
Chaikin Money Flow: -1814221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.47 - 12.81) Sell
Bollinger Bands (100): (11.15 - 14.37) Sell

ARAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.92 Sell
20-day SMA: 1.85 Sell
50-day SMA: 1.86 Sell
200-day SMA: 2.04 Sell
8-day EMA: 1.84 Sell
20-day EMA: 1.86 Sell
50-day EMA: 1.87 Sell
200-day EMA: 2.07 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.48 Sell
20-day SMA: 11.39 Sell
50-day SMA: 12.61 Sell
200-day SMA: 12.8 Sell
8-day EMA: 10.03 Sell
20-day EMA: 11.13 Sell
50-day EMA: 12.15 Sell
200-day EMA: 11.67 Sell

Accuray Earnings Growth & ARAY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.14 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Accuray Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):